136 related articles for article (PubMed ID: 27807862)
21. Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients.
Dihlmann S; Tao S; Echterdiek F; Herpel E; Jansen L; Chang-Claude J; Brenner H; Hoffmeister M; Kloor M
Int J Cancer; 2014 Nov; 135(10):2387-96. PubMed ID: 24729378
[TBL] [Abstract][Full Text] [Related]
22. High pKDR immunohistochemical expression is an unfavourable prognostic biomarker in patients with advanced colorectal cancer treated with chemotherapy plus bevacizumab.
Garde-Noguera J; Gil-Raga M; Evgenyeva E; García JA; Llombart-Cussac A; Camps-Herrero C
Clin Transl Oncol; 2016 Apr; 18(4):405-12. PubMed ID: 26307753
[TBL] [Abstract][Full Text] [Related]
23. L1CAM expression in colorectal cancer identifies a high-risk group of patients with dismal prognosis already in early-stage disease.
Tampakis A; Tampaki EC; Nonni A; Tsourouflis G; Posabella A; Patsouris E; Kontzoglou K; von Flüe M; Nikiteas N; Kouraklis G
Acta Oncol; 2020 Jan; 59(1):55-59. PubMed ID: 31532272
[No Abstract] [Full Text] [Related]
24. Overexpression of G protein-coupled receptor 31 as a poor prognosticator in human colorectal cancer.
Rong YM; Huang XM; Fan DJ; Lin XT; Zhang F; Hu JC; Tan YX; Chen X; Zou YF; Lan P
World J Gastroenterol; 2018 Nov; 24(41):4679-4690. PubMed ID: 30416315
[TBL] [Abstract][Full Text] [Related]
25. The Prognostic Role of STEAP1 Expression Determined via Immunohistochemistry Staining in Predicting Prognosis of Primary Colorectal Cancer: A Survival Analysis.
Lee CH; Chen SL; Sung WW; Lai HW; Hsieh MJ; Yen HH; Su TC; Chiou YH; Chen CY; Lin CY; Chen ML; Chen CJ
Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104516
[TBL] [Abstract][Full Text] [Related]
26. Is neuroendocrine differentiation a prognostic factor in poorly differentiated colorectal cancer?
Chen Y; Liu F; Meng Q; Ma S
World J Surg Oncol; 2017 Mar; 15(1):71. PubMed ID: 28351413
[TBL] [Abstract][Full Text] [Related]
27. A novel sialyl Le(X) expression score as a potential prognostic tool in colorectal cancer.
Schiffmann L; Schwarz F; Linnebacher M; Prall F; Pahnke J; Krentz H; Vollmar B; Klar E
World J Surg Oncol; 2012 May; 10():95. PubMed ID: 22621806
[TBL] [Abstract][Full Text] [Related]
28. Loss of Interleukin-17RA Expression is Associated with Tumour Progression in Colorectal Carcinoma.
Chai BY; Yip WK; Dusa N; Mohtarrudin N; Seow HF
Pathol Oncol Res; 2020 Oct; 26(4):2291-2298. PubMed ID: 32462420
[TBL] [Abstract][Full Text] [Related]
29. Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer.
Bruhn MA; Townsend AR; Khoon Lee C; Shivasami A; Price TJ; Wrin J; Arentz G; Tebbutt NC; Hocking C; Cunningham D; Hardingham JE;
Int J Cancer; 2014 Aug; 135(3):731-41. PubMed ID: 24374727
[TBL] [Abstract][Full Text] [Related]
30. [Relationship between PUMA and BIM expression in colorectal cancer and tumor invasion, metastasis and prognosis].
Yuan H; Tu SL; He XJ
Zhonghua Wai Ke Za Zhi; 2013 Jun; 51(6):547-51. PubMed ID: 24091272
[TBL] [Abstract][Full Text] [Related]
31. [Expression of NF-E1b in colorectal cancer tissues and its clinical significance].
Xu K; Chen L; Di J; Wang Z; Wang A; Wu W; Wu F; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):685-9. PubMed ID: 27353105
[TBL] [Abstract][Full Text] [Related]
32. Loss of H2Bub1 Expression is Linked to Poor Prognosis in Nodal Negative Colorectal Cancers.
Melling N; Grimm N; Simon R; Stahl P; Bokemeyer C; Terracciano L; Sauter G; Izbicki JR; Marx AH
Pathol Oncol Res; 2016 Jan; 22(1):95-102. PubMed ID: 26347467
[TBL] [Abstract][Full Text] [Related]
33. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
34. Reduced expression of alpha catenin is associated with poor prognosis in colorectal carcinoma.
Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava EM; Kosma VM
J Clin Pathol; 1999 Jan; 52(1):10-6. PubMed ID: 10343606
[TBL] [Abstract][Full Text] [Related]
35. Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients.
Peng L; Wang R; Shang J; Xiong Y; Fu Z
Oncotarget; 2017 Feb; 8(9):15057-15070. PubMed ID: 28125800
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of CXCR2 predicts poor prognosis in patients with colorectal cancer.
Zhao J; Ou B; Feng H; Wang P; Yin S; Zhu C; Wang S; Chen C; Zheng M; Zong Y; Sun J; Lu A
Oncotarget; 2017 Apr; 8(17):28442-28454. PubMed ID: 28415702
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance.
Hu L; Chen HY; Han T; Yang GZ; Feng D; Qi CY; Gong H; Zhai YX; Cai QP; Gao CF
Tumour Biol; 2016 Jan; 37(1):837-45. PubMed ID: 26254099
[TBL] [Abstract][Full Text] [Related]
38. Expression of TSP50, SERCA2 and IL-8 in Colorectal Adenoma and Carcinoma: Correlation to Clinicopathological Factors.
Youssef HMK; Radi DA; Abd El-Azeem MA
Pathol Oncol Res; 2021; 27():1609990. PubMed ID: 34744521
[No Abstract] [Full Text] [Related]
39. A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9.
Goos JA; Coupé VM; van de Wiel MA; Diosdado B; Delis-Van Diemen PM; Hiemstra AC; de Cuba EM; Beliën JA; Menke-van der Houven van Oordt CW; Geldof AA; Meijer GA; Hoekstra OS; Fijneman RJ;
Oncotarget; 2016 Jan; 7(2):2123-34. PubMed ID: 26497206
[TBL] [Abstract][Full Text] [Related]
40. Elevated Interleukin-13 Receptor Alpha 1 Expression in Tumor Cells Is Associated with Poor Prognosis in Patients with Invasive Breast Cancer.
Park MH; Kwon HJ; Kim JR; Lee B; Lee SJ; Bae YK
Ann Surg Oncol; 2017 Nov; 24(12):3780-3787. PubMed ID: 28634667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
